BRIP1 and melanoma: Moreover, patients with nonsynonymous somatic mutations in SEPT1-BRIP1 reveal poor overall survival compared to the wild type group without somatic mutations on either SEPT1 and BRIP1 in SKCM (P = 0.0012, log-rank test, Fig 4E), offering a potential genetic interaction in melanoma.